VHCP Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $7.31M | Buy |
1,155,104
+150,000
| +15% | +$950K | 7.86% | 4 |
|
|
2016
Q3 | $4.43M | Hold |
1,005,104
| – | – | 4.36% | 6 |
|
|
2016
Q2 | $2.85M | Buy |
1,005,104
+442,161
| +79% | +$1.26M | 2.96% | 7 |
|
|
2016
Q1 | $1.59M | Buy |
+562,943
| New | +$1.59M | 1.38% | 15 |
|
|
2015
Q3 | – | Sell |
-373,686
| Closed | -$5.58M | – | 19 |
|
|
2015
Q2 | $5.58M | Sell |
373,686
-1,370,670
| -79% | -$20.5M | 1.57% | 14 |
|
|
2015
Q1 | $15.8M | Hold |
1,744,356
| – | – | 3.63% | 10 |
|
|
2014
Q4 | $21.2M | Hold |
1,744,356
| – | – | 5.84% | 5 |
|
|
2014
Q3 | $17.1M | Hold |
1,744,356
| – | – | 7.67% | 6 |
|
|
2014
Q2 | $22.2M | Hold |
1,744,356
| – | – | 11.89% | 3 |
|
|
2014
Q1 | $18.5M | Sell |
1,744,356
-10,000
| -0.6% | -$106K | 9.59% | 3 |
|
|
2013
Q4 | $13.3M | Sell |
1,754,356
-426,300
| -20% | -$3.24M | 7.18% | 5 |
|
|
2013
Q3 | $15.9M | Buy |
2,180,656
+1,167,214
| +115% | +$8.5M | 8.77% | 5 |
|
|
2013
Q2 | $1.57M | Buy |
+1,013,442
| New | +$1.57M | 1.17% | 15 |
|